Format

Send to

Choose Destination
See comment in PubMed Commons below
FEBS Lett. 2010 Mar 5;584(5):954-60. doi: 10.1016/j.febslet.2010.01.034. Epub 2010 Jan 22.

Evaluating bistability of Bax activation switch.

Author information

1
State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, People's Republic of China.

Abstract

Mitochondrial apoptotic pathway is precisely controlled by BCL-2 family. Complex interactions of BCL-2 family proteins constitute a bistable switch of which detailed experimental and theoretical delineation remains elusive. In this paper, combined approaches were used to explore the bistability of Bax activation switch. We found that Bax activation is indeed in an 'all-or-none' manner. The 'variable-delay, snap-action' nature for Bax activation is further explored theoretically. We suggest that bistability is largely attributed to topological structure and shows considerable robustness. Therefore, our study characterizes dynamics and sensitivities in intrinsic apoptotic pathway.

PMID:
20096692
DOI:
10.1016/j.febslet.2010.01.034
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center